Off the Scales

The inside story of the race to develop Ozempic – the world’s first truly effective and safe obesity drug – and its potentially revolutionary effects on public health, and our deeper culture and values. 'A FASCINATING DEEP DIVE' Guardian 'VERY ENGAGING' New Scientist 'ENLIGHTENING' Publishers Weekly A ‘cure’ for obesity has long evaded the pharmaceutical industry, until the development of Ozempic: a diabetes medication that targets the GLP-1 hormone and makes people feel fuller for longer. After decades of research, Ozempic’s creator Novo Nordisk quickly became one of the most valuable companies in Europe. Now it struggles to keep up with its rivals in an explosive and lucrative market for weight-loss injections. The treatment is so effective that it’s already disrupted industries from healthcare to fast food to fashion. Financial investment has